The National Institutes of Health (NIH) is teaming up with the federal health insurance program to develop a “real world data platform” aimed at uncovering the root causes of autism. This initiative was announced recently.
According to a statement from the Department of Health and Human Services (HHS), the NIH plans to work closely with the Centers for Medicare and Medicaid Services (CMS). Together, they will create a database harnessing information from wearable health technology, insurance claims, and electronic medical records.
HHS Director Robert F. Kennedy Jr. emphasized that this collaboration seeks to identify the underlying causes of autism and other chronic conditions.
The partnership intends to focus on a segment of the population that constitutes approximately 36% of Americans who may have an autism diagnosis, with plans to expand the research later to include additional chronic health issues.
The teams at CMS and NIH are setting up secure methods for sharing data, ensuring the exchange is timely while adhering to privacy standards. Concerns arose last month when NIH Director Jay Bhattacharya indicated he would be compiling a database of Americans with autism, which would help establish a national registry.
A source from HHS clarified to various news outlets that an official autism registry has not been created, framing the project instead as a platform for integrating existing data sets. NPR has not verified this information independently.
In a recent statement, Bhattacharya noted that the collaboration with CMS is a significant step towards enhancing public health decisions through real-world data, which could lead to improved health outcomes.
However, alarm bells have been raised within the autism community and privacy advocates regarding potential mishandling of sensitive patient data. Helen Tagger Fulsberg, who directs the Center for Autism Research at Boston University and leads the Autism Scientists Coalition, expressed concern over the misuse of the data collected.
She pointed out that CMS data can reveal specific personal details, posing a risk for individual identification based on this information. Even with assurances of privacy protection, doubts remain about the administration’s ability to secure this data.
Kennedy’s focus on autism indicates a commitment to identifying and potentially eliminating its causes. He previously made controversial claims linking autism to childhood vaccinations and environmental toxins. He referred to autism as a “preventable disease” and has set a target for determining the disorder’s underlying causes by September.
Medical consensus has dismissed the notion that vaccines are responsible for autism, suggesting instead that there is no single cause for the condition. Bhattacharya has since extended the deadline, suggesting that a year may be a more practical timeframe.
Data from the Centers for Disease Control and Prevention indicates that autism prevalence has increased in the U.S., from one in 36 children five years ago to one in 31 in 2022, likely as a result of more robust screening methods being employed.
